跳转至内容
Merck
CN
  • Mechanism of synergistic interactions and its influence on drug release from extended release matrices manufactured using binary mixtures of polyethylene oxide and sodium carboxymethylcellulose.

Mechanism of synergistic interactions and its influence on drug release from extended release matrices manufactured using binary mixtures of polyethylene oxide and sodium carboxymethylcellulose.

Colloids and surfaces. B, Biointerfaces (2013-01-15)
Dasha Palmer, Marina Levina, Dionysios Douroumis, Mohammed Maniruzzaman, David J Morgan, Thomas P Farrell, Ali R Rajabi-Siahboomi, Ali Nokhodchi
摘要

The ability of anionic polymer sodium carboxymethylcellulose to influence the release of four model cationic drugs (chlorpheniramine maleate, venlafaxine hydrochloride, propranolol hydrochloride and verapamil hydrochloride) from extended release (ER) hydrophilic matrices based on non-ionic polymer polyethylene oxide was investigated by X-ray photoelectron spectroscopy (XPS), isothermal titration calorimetry (ITC) and differential scanning calorimetry (DSC). For all studied APIs, a combination of polyethylene oxide with sodium carboxymethylcellulose produced slower drug release compared to the matrices of single polymers. This behaviour was mainly attributed to the interaction of ester/carboxylic acid functionalities to yield H-bonding between the anionic polymer groups and the additionally protonated N-atoms of the active substances. X-ray photoelectron and isothermal titration calorimetry studies confirmed drug-polymer interaction and polymer-polymer interaction (i.e. the PEO binding with negatively charged NaCMC), whilst differential scanning calorimetry indicated the existence of both crystalline and molecularly dispersed active forms in the created complexes. The drug release mechanisms were fitted to various models suggesting diffusion control for the majority of the formulations. The Korsmeyer-Peppas model was found to be the most suitable for description of release profiles of all formulations. The present study showed that XPS and ITC in combination with DSC can be valuable tool to investigate the presence and nature (mechanism) of synergistic interactions between polymers and drugs in extended release matrix tablets.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
羧甲基纤维素 钠盐, Medium viscosity
Sigma-Aldrich
羧甲基纤维素 钠盐, low viscosity
Sigma-Aldrich
羧甲基纤维素钠, viscosity 50-200 cP , c=4% H2O at 25­°C
Sigma-Aldrich
羧甲基纤维素 钠盐, High viscosity
Sigma-Aldrich
羧甲基纤维素钠, viscosity 2500-6000 cP 
Sigma-Aldrich
羧甲基纤维素钠, average Mw ~250,000, degree of substitution 0.9
Sigma-Aldrich
羧甲基纤维素钠, average Mw ~250,000, degree of substitution 1.2
Sigma-Aldrich
(±)-维拉帕米 盐酸盐, ≥99% (titration), powder
Sigma-Aldrich
羧甲基纤维素钠, average Mw ~250,000, degree of substitution 0.7
Sigma-Aldrich
羧甲基纤维素 钠盐, medium viscosity
Sigma-Aldrich
羧甲基纤维素 钠盐, ultra high viscosity, highly purified
Sigma-Aldrich
羧甲纤维素 钠, meets USP testing specifications, Medium viscosity
Supelco
文拉法辛 盐酸盐 溶液, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®
Supelco
Verapamil hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®
Supelco
(±)-维拉帕米 盐酸盐, Pharmaceutical Secondary Standard; Certified Reference Material
维拉帕米, European Pharmacopoeia (EP) Reference Standard
文拉法辛 盐酸盐, European Pharmacopoeia (EP) Reference Standard
文拉法辛, European Pharmacopoeia (EP) Reference Standard